Your browser doesn't support javascript.
loading
Pan-PIM kinase inhibition provides a novel therapy for treating hematologic cancers.
Garcia, Pablo D; Langowski, John L; Wang, Yingyun; Chen, Min; Castillo, Joseph; Fanton, Christie; Ison, Marjorie; Zavorotinskaya, Tatiana; Dai, Yumin; Lu, Jing; Niu, Xiao-Hong; Basham, Stephen; Chan, Julie; Yu, Jianjun; Doyle, Michael; Feucht, Paul; Warne, Robert; Narberes, Jamie; Tsang, Tiffany; Fritsch, Christine; Kauffmann, Audrey; Pfister, Estelle; Drueckes, Peter; Trappe, Joerg; Wilson, Christopher; Han, Wooseok; Lan, Jiong; Nishiguchi, Gisele; Lindvall, Mika; Bellamacina, Cornelia; Aycinena, J Alex; Zang, Richard; Holash, Jocelyn; Burger, Matthew T.
Affiliation
  • Garcia PD; Authors' Affiliations: Oncology Disease Area Research; Global Discovery Chemistry/Oncology and Exploratory Chemistry; MAP Group; Chemical and Pharmaceutical Profiling Group, Novartis Institutes for Biomedical Research, Emeryville, California; Developmental Molecular Pathways, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts; Oncology Disease Area Research; and Center for Proteomic Chemistry, Novartis Institutes for Biomedical Research, Basel, Switzerland.
Clin Cancer Res ; 20(7): 1834-45, 2014 Apr 01.
Article in En | MEDLINE | ID: mdl-24474669

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proto-Oncogene Proteins / Protein Serine-Threonine Kinases / Hematologic Neoplasms / Proto-Oncogene Proteins c-pim-1 Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2014 Type: Article Affiliation country: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proto-Oncogene Proteins / Protein Serine-Threonine Kinases / Hematologic Neoplasms / Proto-Oncogene Proteins c-pim-1 Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2014 Type: Article Affiliation country: Switzerland